AbbVie Care

ABBVIE CARE TERMS & CONDITIONS

  1. Only Australian residents who have been prescribed and dispensed an AbbVie Pty Ltd (ABN 48 156 384 262) (AbbVie) medication for an indication and dosing schedule registered with the Therapeutic Goods Administration (Medication) (together, Medications) by their healthcare professional (HCP) are eligible to enrol in and continue their participation in an AbbVie Care patient support program. 2.Medications for which AbbVie offers a patient support program under AbbVie Care will have a dedicated program specific to the prescribed Medication (Program) (together, Programs).
  2. If enrolment into a Program is for a patient prescribed a paediatric indication of a Medication, and the patient is under 18 years of age, a legal parent/carer/guardian must give consent for the patient to be enrolled in a Program.
  3. Programs are sponsored by AbbVie and managed and administered by AbbVie’s nominated third party providers (Service Providers). Service Providers facilitate all communications with patients through the communication channels offered under the Program.
  4. Participation in a Program is designed to complement and support the prescribing instructions of an HCP who CPHCwho is responsible for prescribing the Medication for a specific medical condition (Prescribing Specialist).
  5. Each Program may offer a range of health, wellness and/or related support services. The range of activities and services offered is specific to each Medication and will vary between Programs. All services offered under the Programs are optional, allowing patients to opt into all or a selection of the available services, and opt out of any of the available services at any time.
  6. A Program does not replace the advice of a Prescribing Specialist or other HCP. Patients should speak to their Prescribing Specialist if they have any questions or concerns about their treatment. Patients should also refer to their Medications Consumer Medicines Information available at www.medsinfo.com.au or by calling AbbVie Medical Information on 1800 252 224 if they have any further questions or concerns.
  7. The eligibility of a patient to remain enrolled in a Program is determined by the criteria outlined in paragraph 1 above, which will be verified on an ongoing basis by Service Providers (e.g. by asking the patient if they are still taking a Medication). AbbVie reserves the right to discontinue the provision of services to a patient under a Program, if a patient does not meet the eligibility criteria.
  8. Patients may opt out of any of the Services offered under a Program or the entire Program at any time by: calling 1800 222 843, or writing to AbbVie Care Team at AbbVie Care, Reply Paid 86675, GPO Box 2331 SYDNEY NSW 2001 (no stamp required), or follow the opt out instructions in an electronic communication.
  9. If patients opt out of a Program, personal information collected from them during their participation in a Program may still be held for purposes permitted by law, including reporting purposes. To the extent personal information is retained, it will be handled in accordance with the Program Privacy Notice.
  10. AbbVie reserves the right to terminate any or all of the Programs, or change and/or cease providing any of the services under a Program with reasonable notice at any time.

Services

  1. The Programs may offer all or some of the following services:
    1. Self-Injection Training (for injectable products) - involves training on appropriate self-injection technique. Following a patient’s enrolment, their personal information will be provided to a third-party that will contact the patient to arrange training.
    2. Health Coaching Services - involves support from an allied healthcare professional. Following enrolment, the relevant Provider will contact the patient to help identify a health goal the patient wishes to work towards and may also provide information about additional support services. The Programs may also offer ancillary products (e.g. sharps containers) to patients to assist with quality use of their Medication.
    3. General Health and Wellness Information – involves regular communications covering a range of educational topics through different communication channels, reminders about optional Program offerings and offers to participate in surveys.
    4. Reminder Services – may involve reminder services regarding the timing of a patient’s Medication, the collection of their prescription, and appointments with their Prescribing Specialist. The Reminder Services provided by a Program are to assist with the usual medication reminder methods that a patient has adopted for the timing of their Medication, the collection of their prescription, and appointments with their Prescribing Specialist. Patients should not rely solely on this service to remind them of the actions required.
    5. Online and mobile platforms – involves access to a password protected, comprehensive range of online support services and management tips at www.abbviecare.com.au, including support tools and information relating to the Medication.
    6. Medication Management Services – may include the following:
      1. Getting Started includes a series of communications regarding whether or not a patient has received their prescription from their Prescribing Specialist, guidance on the logistics of their treatment journey, and preparing for the next pharmacy visit; and
      2. Staying on Track includes communications at key times to assist with managing a patient’s appointment schedule (including with their Prescribing Specialist and appointments for pathology tests, if relevant);

The Staying on Track communications are to assist patients with their usual reminder methods that they have adopted for managing their appointment schedules. Patients should not rely solely on these services to remind them of the actions required.

How to enrol in a Program

  1. Patients may enrol in a Program either by:
  1. self-enrolment – at www.abbviecare.com.au, by phoning 1800 222 843, or emailing support@abbviecare.com.au;
  2. Prescribing Specialist’s referral (when available); or
  3. Pharmacist’s referral (when available).
  1. In order to enrol in a Program and opt into any or all of the available services, patients must acknowledge that they have understood and agreed to the AbbVie Care Terms and Conditions and the Program Privacy Notice.
  2. If a patient is referred for enrolment by their Prescribing Specialist, the patient’s contact information (email address and/or phone number) will be provided to a Service Provider, who will contact the patient to complete their enrolment.
  3. Pharmacists may receive a payment from AbbVie as a result of referring a patient for enrolment in a Program.

PRIVACY NOTICES

Before submitting any information and agreeing to enrol in a Program, patients must consent to the Patient Privacy Notice.

CLA-AU-250024 November 2025